Ye Ding, Huang Qiuchi, Li Qilong, Jiang Xiyi, Mamat Mayila, Tang Mengling, Wang Jianbing, Chen Kun
Department of Epidemiology and Health Statistics, Zhejiang University School of Public Health, Hangzhou, 310058, China.
Jiashan Institute of Cancer Prevention and Treatment, Jiaxing, 314100, China.
Dig Dis Sci. 2017 Sep;62(9):2532-2541. doi: 10.1007/s10620-017-4648-1. Epub 2017 Jun 20.
The fecal immunochemical test (FIT) has been widely used in preliminary screening for colorectal cancer (CRC). The high-risk factor questionnaire (HRFQ) and quantitative risk-assessment method (QRAM) are recommended for estimating the risk of CRC qualitatively and quantitatively in China.
We aimed to prospectively compare the diagnostic values of CRC preliminary screening methods to identify which method is preferable as a screening strategy.
Individuals aged 40-74 years old were enrolled in a mass CRC screening program from January 1, 2007 to December 31, 2014, in Jiashan County, Zhejiang Province, China. FIT of two stool specimens at 1-week intervals was performed by laboratory personnel and face-to-face interviews were conducted by trained investigators. Screening data in the program were linked to a CRC surveillance and registry system, and CRC cases reported in the system were regarded as true patients.
A total of 96,043 subjects were included. The sensitivity and specificity of FIT for detecting CRC cases were 75.49% (95% CI 69.84-80.39) and 90.36% (95% CI 90.17-90.54), respectively. QRAM was more sensitive (p < 0.001) and less specific (p < 0.001) than HRFQ. The sensitivity and specificity of FIT along with HRFQ were 86.56% (95% CI 81.81-90.22) and 81.37% (95% CI 81.12-81.62), and those of FIT along with QRAM were 88.93% (95% CI 84.47-92.23) and 73.95% (95% CI 73.67-74.23).
Our findings suggest that CRC preliminary screening with FIT and QRAM in parallel has high sensitivity and satisfactory specificity, and is a useful strategy in mass screening programs.
粪便免疫化学检测(FIT)已广泛应用于结直肠癌(CRC)的初步筛查。在中国,高危因素问卷(HRFQ)和定量风险评估方法(QRAM)被推荐用于定性和定量评估CRC风险。
我们旨在前瞻性地比较CRC初步筛查方法的诊断价值,以确定哪种方法作为筛查策略更可取。
2007年1月1日至2014年12月31日,在中国浙江省嘉善县,40-74岁的个体被纳入大规模CRC筛查项目。实验室人员每隔1周对两份粪便标本进行FIT检测,训练有素的调查人员进行面对面访谈。该项目中的筛查数据与CRC监测和登记系统相关联,系统中报告的CRC病例被视为真正的患者。
共纳入96,043名受试者。FIT检测CRC病例的敏感性和特异性分别为75.49%(95%CI 69.84-80.39)和90.36%(95%CI 90.17-90.54)。QRAM比HRFQ更敏感(p<0.001),特异性更低(p<0.001)。FIT联合HRFQ的敏感性和特异性分别为86.56%(95%CI 81.81-90.22)和81.37%(95%CI 81.12-81.62),FIT联合QRAM的敏感性和特异性分别为88.93%(95%CI 84.47-92.23)和73.95%(95%CI 73.67-74.23)。
我们的研究结果表明,FIT和QRAM并行进行CRC初步筛查具有较高的敏感性和令人满意的特异性,是大规模筛查项目中的一种有用策略。